Titan Biotech Ltd
TITANBIOBSE
₹408.60▲ +1.70 (+0.42%)
Whole company worth₹1,688 Cr
Price for ₹1 of profit₹57
1-year range₹202 – ₹556
The short version
A slow-growing, profitable business — priced at a steep premium to what it earns.
What Titan Biotech does
Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products
Worked out from Titan Biotech's own filed results and exchange data, in plain words. Where a finance term matters, we say what it means.
01What does it do?
Titan Biotech is a small-sized company in specialty chemicals.
Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products
- Whole company is worth
- ₹1,688 crore
- Run by
- NARESH KUMAR SINGLA
- Shareholders
- 19,049 people
- Listed since
- 1994
A small company by stock-market value — these tend to move more sharply.
02Is it growing?
Sales have grown 8% a year for 5 years.
At that pace a business doubles in size roughly every 9 years. Profit, though, fell 1% a year over the same stretch.
Point at a bar for exact figures · amounts in ₹ crore
03Does it make money?
Out of every ₹100 it sells, it keeps ₹14 as profit.
Here is where the money from Titan Biotech's sales went in FY26, the latest full year it has reported.
₹47
₹31
₹14
- ₹47Making or buying what it sellsraw materials, stock, goods bought for resale
- ₹31Running the businessstaff, rent, marketing, power and everything else
- ₹0.4Interest on its loansthe cost of borrowed money
- ₹2.4Wear and tearmachines, stores and buildings losing value over time
- ₹5.2Taxincome tax paid to the government
- ₹14Profit it keepswhat is left for the company's owners
On the money its owners have put in
It earns ₹16 a year on every ₹100 its owners have invested.
Bank FD ~₹6–7
₹16
₹0₹10₹20₹30₹40
That figure is called return on equity (ROE). Between ₹12 and ₹20 is a respectable return. For comparison, a bank fixed deposit pays roughly ₹6–7.
Does the profit turn into cash?
For every ₹100 of profit it reported, ₹94 actually came in as cash.
Profit it reported₹76 Cr
Cash its business brought in₹72 Cr
Over the last 3 years: ₹76 crore of profit and ₹72 crore of cash from its day-to-day business. Profit that shows up as cash is the most believable kind.
04Is the price high or low?
You pay ₹57 for every ₹1 of profit it makes in a year.
This is the P/E ratio: share price divided by a year's profit per share. A P/E of 57 means buyers are paying for about 57 years of today's profit up front.
The share price over the past year
It is 26% below its highest price of the past year and 102% above its lowest.
05Who owns it?
Its founders and parent group own 56 of every 100 shares — they control the company.
If the company were split into 100 equal shares, this is who would hold them. 19,049 people and institutions hold its shares.
As filed for the quarter ending 30 Sept 2026. Arrows show the change since the quarter before, in percentage points.
06What is going well, and what to watch
One thing going well, one thing worth watching.
Picked out of the numbers above by fixed rules — the same rules for every company — so nothing here is somebody's opinion.
Going well
- Has almost no debt — it is not at the mercy of lenders.
Worth watching
- Thinly traded — only about ₹73 lakh of shares change hands a day, so buying or selling can move the price.
07What happened lately?
Latest quarter: sales up 27%, profit up 58%.
Apr–Jun 2026 is the most recent quarter it has reported. Each figure is compared with the same three months a year earlier, because many businesses sell more in some seasons than others.
Sales
₹59 Cr
▲ 27.2% on a year earlier
Profit
₹11 Cr
▲ 58.3% on a year earlier
No notable developments in the last few weeks.
Advanced view
Every number, every table, the full chart.
Ten years of statements, quarterly results, peers side by side, technical indicators, analyst estimates, bulk deals and filings.
Ask DoXy
Still have a question about Titan Biotech?
This page describes Titan Biotech using its reported figures and exchange data. It is for information only and is not investment advice or a recommendation to buy, sell or hold. DocStoX is not a SEBI-registered investment adviser or research analyst.
Titan Biotech Ltd (TITANBIO): company summary
The company's business improved, with annual revenue rising 31.8% and annual net profit rising 38.8%.
Titan Biotech Ltd (TITANBIO) is a micro-cap Chemicals company valued at ₹1,688 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Titan Biotech Ltd last traded at ₹408.6, modestly up 0.42% on the day.
- Recent developments
- 2026-09-03, the company's board approved a 1:4 bonus issue, which is a positive corporate action. The company also announced a buyback split bonus on 2026-10-23.
- Financial performance
- The company's business improved, with annual revenue rising 31.8% and annual net profit rising 38.8%. The latest quarter saw revenue rise 27.2% and net profit rise 58.3% compared to the same quarter a year earlier. The net profit margin widened by 0.7 percentage points to 14.5%, while return on equity remained at 16.5%.
- Valuation multiples
- The stock trades at 56.5 times earnings, 9.88 times book value. It yields 0.1%.
- Things to watch
- The stock is 26.8% below its 52-week high. The company's profit growth slowed over the past five years, with a 1.4% decline in annual profit. The company's market cap is ₹1,681 crore, which is considered a micro-cap.
- Where it stands
- Titan Biotech Ltd reported annual revenue of ₹206 crore and annual net profit of ₹30 crore as of 2026-03-31. The latest quarter ended on 2026-06-30 with revenue of ₹59 crore and net profit of ₹11 crore. The company's promoter holding is 55.78% as of 2026-09-30.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
More Chemicals stocks · Specialty Chemicals
Explore Titan Biotech Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Titan Biotech Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Titan Biotech Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing